4//SEC Filing
Jacks Tyler 4
Accession 0001127602-18-035752
CIK 0000318154other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 8:46 PM ET
Size
8.6 KB
Accession
0001127602-18-035752
Insider Transaction Report
Form 4
AMGEN INCAMGN
Jacks Tyler
Director
Transactions
- Exercise/Conversion
Nqso (Right to Buy)
2018-12-06−20,000→ 0 totalExercise: $82.60From: 2013-07-31Exp: 2022-07-31→ Common Stock (20,000 underlying) - Sale
Common Stock
2018-12-06$195.41/sh−20,000$3,908,232→ 8,979 total - Exercise/Conversion
Common Stock
2018-12-06$82.60/sh+20,000$1,652,000→ 28,979 total
Footnotes (2)
- [F1]The price reported is an average price. the prices ranged from $195.28 to $195.83 per share for this cashless exercise of 20,000 stock options expiring July 31, 2022. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- [F2]These shares include 467 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001464237
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 8:46 PM ET
- Size
- 8.6 KB